561 related articles for article (PubMed ID: 15147236)
1. 1alpha,25-dihydroxyvitamin D3 inducible transcription factor and its role in the vitamin D action.
Nezbedova P; Brtko J
Endocr Regul; 2004 Mar; 38(1):29-38. PubMed ID: 15147236
[TBL] [Abstract][Full Text] [Related]
2. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D receptor displays DNA binding and transactivation as a heterodimer with the retinoid X receptor, but not with the thyroid hormone receptor.
Thompson PD; Hsieh JC; Whitfield GK; Haussler CA; Jurutka PW; Galligan MA; Tillman JB; Spindler SR; Haussler MR
J Cell Biochem; 1999 Dec; 75(3):462-80. PubMed ID: 10536369
[TBL] [Abstract][Full Text] [Related]
4. DNA bending is induced by binding of vitamin D receptor-retinoid X receptor heterodimers to vitamin D response elements.
Kimmel-Jehan C; Darwish HM; Strugnell SA; Jehan F; Wiefling B; DeLuca HF
J Cell Biochem; 1999 Aug; 74(2):220-8. PubMed ID: 10404392
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D receptor: key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands.
Jurutka PW; Bartik L; Whitfield GK; Mathern DR; Barthel TK; Gurevich M; Hsieh JC; Kaczmarska M; Haussler CA; Haussler MR
J Bone Miner Res; 2007 Dec; 22 Suppl 2():V2-10. PubMed ID: 18290715
[TBL] [Abstract][Full Text] [Related]
6. Synthetic LXXLL peptide antagonize 1,25-dihydroxyvitamin D3-dependent transcription.
Pike JW; Pathrose P; Barmina O; Chang CY; McDonnell DP; Yamamoto H; Shevde NK
J Cell Biochem; 2003 Feb; 88(2):252-8. PubMed ID: 12520523
[TBL] [Abstract][Full Text] [Related]
7. Evidence for tissue- and cell-type selective activation of the vitamin D receptor by Ro-26-9228, a noncalcemic analog of vitamin D3.
Peleg S; Ismail A; Uskokovic MR; Avnur Z
J Cell Biochem; 2003 Feb; 88(2):267-73. PubMed ID: 12520525
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D analogs as therapeutic agents: a clinical study update.
Wu-Wong JR; Tian J; Goltzman D
Curr Opin Investig Drugs; 2004 Mar; 5(3):320-6. PubMed ID: 15083599
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention.
Haussler MR; Haussler CA; Bartik L; Whitfield GK; Hsieh JC; Slater S; Jurutka PW
Nutr Rev; 2008 Oct; 66(10 Suppl 2):S98-112. PubMed ID: 18844852
[TBL] [Abstract][Full Text] [Related]
10. Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation.
Bettoun DJ; Burris TP; Houck KA; Buck DW; Stayrook KR; Khalifa B; Lu J; Chin WW; Nagpal S
Mol Endocrinol; 2003 Nov; 17(11):2320-8. PubMed ID: 12893883
[TBL] [Abstract][Full Text] [Related]
11. Integration of the NfkappaB p65 subunit into the vitamin D receptor transcriptional complex: identification of p65 domains that inhibit 1,25-dihydroxyvitamin D3-stimulated transcription.
Lu X; Farmer P; Rubin J; Nanes MS
J Cell Biochem; 2004 Jul; 92(4):833-48. PubMed ID: 15211579
[TBL] [Abstract][Full Text] [Related]
12. All natural DR3-type vitamin D response elements show a similar functionality in vitro.
Toell A; Polly P; Carlberg C
Biochem J; 2000 Dec; 352 Pt 2(Pt 2):301-9. PubMed ID: 11085922
[TBL] [Abstract][Full Text] [Related]
13. Identification of the functional vitamin D response elements in the human MDR1 gene.
Saeki M; Kurose K; Tohkin M; Hasegawa R
Biochem Pharmacol; 2008 Aug; 76(4):531-42. PubMed ID: 18602086
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells.
Pramanik R; Asplin JR; Lindeman C; Favus MJ; Bai S; Coe FL
Cell Immunol; 2004; 232(1-2):137-43. PubMed ID: 15876428
[TBL] [Abstract][Full Text] [Related]
15. Structural evaluation of the agonistic action of a vitamin D analog with two side chains binding to the nuclear vitamin D receptor.
Väisänen S; Peräkylä M; Kärkkäinen JI; Uskokovic MR; Carlberg C
Mol Pharmacol; 2003 Jun; 63(6):1230-7. PubMed ID: 12761332
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D receptor interacts with DnaK/heat shock protein 70: identification of DnaK interaction site on vitamin D receptor.
Swamy N; Mohr SC; Xu W; Ray R
Arch Biochem Biophys; 1999 Mar; 363(2):219-26. PubMed ID: 10068443
[TBL] [Abstract][Full Text] [Related]
17. Role of dihydroxyvitamin D(3) and its nuclear receptor in novel directed therapies for cancer.
Ondková S; Macejová D; Brtko J
Gen Physiol Biophys; 2006 Dec; 25(4):339-53. PubMed ID: 17356228
[TBL] [Abstract][Full Text] [Related]
18. Salt concentration determines 1,25-dihydroxyvitamin D3 dependency of vitamin D receptor-retinoid X receptor--vitamin D-responsive element complex formation.
Kimmel-Jehan C; Jehan F; DeLuca HF
Arch Biochem Biophys; 1997 May; 341(1):75-80. PubMed ID: 9143355
[TBL] [Abstract][Full Text] [Related]
19. Two basic amino acids C-terminal of the proximal box specify functional binding of the vitamin D receptor to its rat osteocalcin deoxyribonucleic acid-responsive element.
Hsieh JC; Whitfield GK; Jurutka PW; Haussler CA; Thatcher ML; Thompson PD; Dang HT; Galligan MA; Oza AK; Haussler MR
Endocrinology; 2003 Nov; 144(11):5065-80. PubMed ID: 12960019
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D receptor ligands for osteoporosis.
Cheskis BJ; Freedman LP; Nagpal S
Curr Opin Investig Drugs; 2006 Oct; 7(10):906-11. PubMed ID: 17086935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
